Results

Total Results: over 10,000 records

Showing results for "discussed".

8041. Spotlight on Georgia -- National Evaluation of the CHIPRA Quality Demonstration Grant Program (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-georgia-state-snapshot.pdf
      January 01, 2018 - Spotlight on Georgia -- National Evaluation of the CHIPRA Quality Demonstration Grant Program This brief highlights the major strategies, lessons learned, and outcomes from Georgia’s experience from February 2010 to February 2016 with the quality demonstration funded by the Centers for Medicare & Medicaid Service…

8042. Engage the Team and Applying CUSP in the ICU Setting Facilitator Guide
      www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/cusp-icu-slides.pptx
      April 01, 2022 - Engage the Team and Applying CUSP in the ICU Setting Facilitator Guide Engaging the Team and Applying CUSP in the ICU Setting AHRQ Safety Program for Intensive Care Units: Preventing CLABSI and CAUTI AHRQ Pub. No. 17(22)-0019 April 2022 Objectives Define key aspects of safety culture and why it is important Recall…

8043. Executive Summary | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/reports/engage/summary.html
      March 01, 2017 - Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families Executive Summary Previous Page Next Page Table of Contents Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families Executive Summary Introduction Limitations of …

8044. Central Venous Catheter Maintenance
      www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/central-catheter-maintenance.pptx
      April 01, 2022 - Central Venous Catheter Maintenance Central Venous Catheter Maintenance Maintaining Awareness and Proper Care of Catheters in Place AHRQ Safety Program for Intensive Care Units: Preventing CLABSI and CAUTI AHRQ Pub. No. 17(22)-0019 April 2022 1 Step 2. Maintenance Disrupting the Life Cycle of a Catheter Device1…

8045. Making It Work Tip Sheet: Managing Urinary Retention and Catheterization in Intensive Care Unit Patients With Primary Neurologic Disorders (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/urinary-retention.pdf
      April 01, 2022 - Making It Work Tip Sheet: Managing Urinary Retention and Catheterization in Intensive Care Unit Patients With Primary Neurologic Disorders AHRQ Safety Program for Intensive Care Units: Preventing CLABSI and CAUTI Making It Work Tip Sheet Managing Urinary Retention and Catheterization in Intensive Care …

8046. Accountability in Patient Safety | PSNet
      psnet.ahrq.gov/perspective/accountability-patient-safety
      January 01, 2018 - Annual Perspective Accountability in Patient Safety Christopher Moriates, MD, and Robert M. Wachter, MD | January 1, 2015  View more articles from the same authors. Citation Text: Moriates C, Wachter R. Accountability in Patient Safety. PSNet [internet]. Rock…

8047. Additional Topic Areas | Agency for Healthcare Research and Quality
      www.ahrq.gov/ncepcr/reports/2024-annual-report/recent-grants-additional-topics.html
      May 01, 2024 - Investments in Primary Care Research for 2021 and 2022 Additional Topic Areas Previous Page Next Page Table of Contents Investments in Primary Care Research for 2021 and 2022 Acknowledgments and Authors Message from the Acting Director of AHRQ's National Center for Excellence in Primary Care Res…

8048. Final Report, Year 3: CDS Connect (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
      January 01, 2019 - These are discussed in greater detail in the Lessons Learned section of the document. … the period of performance to ensure work objectives were met and that emerging opportunities were discussed … These approaches were discussed with healthcare organizations to explore their interest in collaborating … The teams also discussed and finalized the USPSTF recommendations of highest priority to b.well, based … Additional information, as well as the findings of both, are discussed in Section 3.4.1.

8049. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
      November 01, 2016 - PREGNANCY, INCLUDING PRETERM BIRTH #12 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 12: Pregnancy, Including Preterm Birth Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road …

8050. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
      November 01, 2016 - PREGNANCY, INCLUDING PRETERM BIRTH #12 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 12: Pregnancy, Including Preterm Birth Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane …

8051. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
      March 11, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: March 11, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism I. Background and Objectives for th…

8052. Project Context | Agency for Healthcare Research and Quality
      www.ahrq.gov/data/apcd/envscan/context.html
      June 01, 2017 - some of the methodological considerations pertaining to using APCD data for measurement that have been discussed

8053. Tracking Patient Outcomes | The Academy
      integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/monitor-patient-and-program-progress/tracking-patient-outcomes
      February 01, 2024 - As previously discussed in Co-Occurring Behavioral Health Disorders , comorbid conditions such as depression

8054. Poor Prognosis | PSNet
      psnet.ahrq.gov/web-mm/poor-prognosis
      March 15, 2016 - has a financial arrangement or other relationship with the manufacturers of any commercial products discussed

8055. Defensive Medicine: "Glowing" with Pain | PSNet
      psnet.ahrq.gov/web-mm/defensive-medicine-glowing-pain
      November 01, 2012 - When she discussed the patient with the providers involved, many of the physicians expressed that the

8056. Don't Push | PSNet
      psnet.ahrq.gov/web-mm/dont-push
      March 02, 2011 - of Medicine Disclosures: The author is a consultant to the following companies whose drugs are discussed

8057. Statistical Brief #183: The Long-Term Uninsured in America, 2002–2005: Estimates for the U.S. Population under Age 65 (pdf file)
      meps.ahrq.gov/data_files/publications/st183/stat183.pdf
      August 01, 2007 - All differences between estimates discussed in the text are statistically significant at the 0.05 level

8058. Statistical Brief #123: The Long-Term Uninsured in America, 2000–2003: Estimates for the U.S. Population under Age 65 (pdf file)
      meps.ahrq.gov/data_files/publications/st123/stat123.pdf
      March 01, 2006 - All differences between estimates discussed in the text are statistically significant at the 0.05 level

8059. STATISTICAL BRIEF #277: Trends in Outpatient Prescription Gastrointestinal Agents Purchases and Expenditures for the U.S. Civilian Noninstitutionalized Population, 1997 and 2007
      meps.ahrq.gov/data_files/publications/st277/stat277.shtml
      January 01, 2010 - All differences discussed in the text are statistically significant at the 0.05 level.

8060. Statistical Brief #121: Out-of-Pocket Expenditures on Health Care and Insurance Premiums among the Nonelderly Population, 2003 (pdf file)
      meps.ahrq.gov/data_files/publications/st121/stat121.pdf
      March 01, 2006 - All differences between estimates discussed in the text are statistically significant at the 0.05 level